mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.016 |
0.8 |